Viewing nowTerra En Tablet 2 mg (Terazosin Hydrochloride)
Terazosin Hydrochloride Hydrate 2.374mg
Tablet · Prescription medication
Huons Meditech Co., Ltd.

MFDS item code 201505004 · Approved 2015.07.23 · Insurance code 670402490
Improvement of urinary disorders and hypertension caused by benign prostatic hyperplasia
This medication is used to treat urinary disorders associated with benign prostatic hyperplasia and mild to moderate hypertension.
1. Urinary disorders due to benign prostatic hyperplasia - Initial dose: The initial dose of terazosin hydrochloride is 1 mg taken orally before bedtime and this dosage should not be exceeded. It is essential to monitor the patient's condition carefully after the first administration. - Maintenance dose: Gradually increase the dose until symptoms improve, administering 5-10 mg orally once daily. - When used in conjunction with thiazide diuretics and other antihypertensive agents, the dose should be reduced and increased as necessary.
This medication should not be used in certain patients. For instance, it should not be taken by patients with allergies to this medication or similar types of drugs, children under 12 years of age, and patients with genetic lactose intolerance. Patients with severely impaired liver or kidney function, or certain heart and blood pressure-related diseases should use this medication with caution. Additionally, patients who have had allergic reactions to the coloring agents included in this medication should be cautious. Taking this medication may lead to various side effects ranging from mild dizziness to severe cases of fainting. This is particularly likely when starting treatment or suddenly increasing the dosage, so caution is advised. During treatment, various symptoms such as headaches, drowsiness, insomnia, dyspepsia, respiratory symptoms, urinary problems, skin rashes, etc. may occur, and if any unusual symptoms appear, one should immediately consult a doctor. This medication has blood pressure-lowering effects, so caution should be exercised when driving or operating dangerous machinery. Additionally, dizziness or fainting risk may occur when suddenly changing positions, so it is advisable to move slowly. Although this medication is used to treat benign prostatic hyperplasia, it may have similar symptoms as prostate cancer, so it is crucial to confirm the absence of cancer before starting treatment. Patients undergoing cataract surgery must inform their ophthalmologist about the use of this medication, as certain complications may occur during surgery requiring special attention. No significant interactions arise from taking this drug with various other medications. However, caution is warranted when taking it alongside antihypertensive drugs as it may lead to excessively low blood pressure. Pregnant or breastfeeding women should only use this medication under a physician's judgment due to uncertain safety, and breastfeeding should be avoided if possible while using this medication. This medication's safety and effectiveness have not been fully confirmed in children or elderly patients, so it should be used with special caution. It is recommended that the elderly start with a low dose. In cases of overdose, blood pressure may drop sharply, necessitating immediate medical treatment, and this medication is not removed by dialysis, so alternative treatment methods are required. This medication should be kept out of the reach of children and it is safer not to transfer it to other containers.
Fainting, excessive orthostatic hypotension, allergic reactions (including anaphylaxis)
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture; therefore, it should be stored in a tightly closed container. It is important to maintain the storage temperature between 1 and 30 degrees Celsius to preserve the drug's effectiveness and safety for a longer time.
Light orange to yellow round tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTerazosin Hydrochloride Hydrate 2.374mg
Tablet · Prescription medication
Huons Meditech Co., Ltd.

Terazosin Hydrochloride Hydrate 1.187mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Terazosin Hydrochloride Hydrate 2.374mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Terazosin Hydrochloride Hydrate 5.935mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Terazosin Hydrochloride Hydrate 2.374mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Terazosin Hydrochloride Hydrate 2.374mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Terazosin Hydrochloride Hydrate 2.374mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Terazosin Hydrochloride Hydrate 2.374mg
Tablet · Prescription medication
(Hawon Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.